Indeterminate Thyroid Nodule Size May Predict RFA Success
In a functionally screened cohort, there was an 85% likelihood of being free of local treatment failure at 3 years, with outcomes favoring nodules smaller than 3 cm.
By
Andrea Surnit
June 17, 2026
Clinical Scorecard: Indeterminate Thyroid Nodule Size May Predict RFA Success
At a Glance
Category Detail
Condition Key Mechanisms Radiofrequency ablation (RFA) following imaging screening as per study findings Target Population Care Setting
Key Highlights
85% probability of remaining free of local treatment failure at 3 years (source needed) Local treatment failure occurred in about 14% of patients (source needed) Volume reduction reached 91% at 3 years (source needed) 93% of nodules smaller than 3 cm remained free of local treatment failure (source needed) No local or distant metastases observed during follow-up (source needed) Guideline-Based Recommendations
Diagnosis
Preprocedural risk stratification with imaging techniques (source needed) Management
Radiofrequency ablation for patients declining surgery (source needed) Monitoring & Follow-up
Follow-up fine-needle aspiration to assess cytology (source needed) Risks
Potential vocal cord palsy-related hoarseness (source needed) Patient & Prescribing Data
109 patients with indeterminate thyroid nodules
Larger nodules more likely to experience local treatment failure
Clinical Best Practices
Consider baseline nodule diameter for patient selection and counseling (source needed) Monitor symptom and cosmetic scores over time (source needed) Related Resources & Content
